EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Impact of Candida Growth in Organ Preservation Fluid: A Retrospective Analysis of Abdominal Solid Organ Transplants

Lior Cohen Yatziv, Scott Borgetti, Alfredo Mena Lora, Christine Zaky, Gabriela Mendez Gonzalez

Antimicrobial Stewardship & Healthcare Epidemiology · 2026-08 · 6 (S1) · s129-s130

DOI: 10.1017/ash.2026.10637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 23.06.2026. Verfasst von Lior Cohen Yatziv und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Candida growth in organ preservation fluid (OPF) is uncommon, with reported incidence ranging up to 4% of OPF. Its clinical significance is unclear, as many recipients remain asymptomatic, while on rare occasions, transmission can lead to severe donor-derived infections, most notably mycotic aneurysms, graft loss, and fatal hemorrhage. The current American Society of Transplantation (AST) guidance recommends prompt antifungal therapy when Candida is identified; however, real-world practice patterns and outcomes are not well described.

Methods

We conducted a retrospective cohort study of adult solid organ transplant recipients at a tertiary academic center from January 2020 through October 2025. Patients with Candida-positive OPF cultures were identified through the medical record. We collected recipients' and donors' demographics, microbiological profiles, antifungal management, and clinical outcomes. Invasive candidiasis was defined as Candida isolated from blood or deep tissue/fluid within 90 days of transplant.

Results

We identified 55 solid organ transplant recipients with Candida-positive OPF cultures (34 Kidney, 9 Liver, 12 Kidney-Pancreas). The most common isolates (37 patients) were C. albicans and C. glabrata. Treatment patterns and outcomes varied by organ type. Among Kidney recipients, 20.5% (7/34) received no antifungal therapy; notably, none of these untreated patients developed invasive candidiasis, graft loss, or vascular complications. All Liver recipients (n=9) received antifungal therapy, predominantly for

Zitieren

APA

Yatziv, L. C., Borgetti, S., Lora, A. M., Zaky, C., & Gonzalez, G. M. (2026). Clinical Impact of Candida Growth in Organ Preservation Fluid: A Retrospective Analysis of Abdominal Solid Organ Transplants. Antimicrobial Stewardship & Healthcare Epidemiology, 6(S1), s129-s130. https://doi.org/10.1017/ash.2026.10637

Vancouver

Yatziv LC, Borgetti S, Lora AM, Zaky C, Gonzalez GM. Clinical Impact of Candida Growth in Organ Preservation Fluid: A Retrospective Analysis of Abdominal Solid Organ Transplants. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(S1):s129-s130. doi:10.1017/ash.2026.10637

BibTeX
@article{Yatziv2026,
  author = {Yatziv, Lior Cohen and Borgetti, Scott and Lora, Alfredo Mena and Zaky, Christine and Gonzalez, Gabriela Mendez},
  title = {Clinical Impact of Candida Growth in Organ Preservation Fluid: A Retrospective Analysis of Abdominal Solid Organ Transplants},
  journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
  year = {2026},
  volume = {6},
  number = {S1},
  pages = {s129--s130},
  doi = {10.1017/ash.2026.10637}
}
Kostenlos starten →